上海微创心脉医疗科技(集团)股份有限公司关于使用部分暂时闲置募集资金进行现金管理的公告

Core Viewpoint - The company plans to utilize part of its temporarily idle raised funds for cash management to enhance the efficiency of fund usage and maximize shareholder returns while ensuring that the investment plans remain unaffected [3][20]. Investment Overview - Investment Purpose: The aim is to maximize shareholder interests by effectively utilizing temporarily idle raised funds for cash management without impacting the normal investment plans [3]. - Investment Amount: The company intends to use no more than RMB 100,000 million (including the principal) for cash management, with the funds being available for rolling use within this limit [4][13]. - Funding Source: As of June 30, 2025, the company has raised funds through its initial public offering, with specific amounts allocated to various projects [5][6]. Investment Method - Investment Products: The company plans to invest in high-safety, high-liquidity products, including but not limited to structured deposits, notice deposits, time deposits, large-denomination certificates of deposit, and income certificates [7][11]. - Investment Duration: The investment period is set for 12 months from the date of approval by the board of directors [8][13]. - Implementation Method: The board of directors has authorized the management team to handle the purchase of investment products, with the finance department responsible for organizing the implementation [9][13]. Cash Management Returns - The returns from cash management will be prioritized for supplementing any shortfall in investment amounts for projects and for the company's daily operational liquidity, adhering to regulatory requirements [10][21]. Recent Cash Management Situation - In the past 12 months, the company had previously approved the use of up to RMB 130,000 million for cash management, maintaining the same investment product criteria [11][12]. Review Procedures - The board of directors approved the cash management proposal on January 19, 2026, ensuring that it does not affect the normal operation of the investment plans [13][14]. Impact on the Company - The planned cash management will not affect the normal turnover of funds or the operation of investment projects, and it aims to improve fund efficiency and generate returns for shareholders [20]. Opinions of Intermediaries - The sponsor institution has confirmed that the cash management plan complies with legal procedures and regulations, ensuring that it does not alter the intended use of raised funds or negatively impact the company's main business [21][22].